| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.521 | 0.003 | 0.521 | Phosphodiesterase 4A inhibitor | 0.436 0.004 CID_779516 0.351 0.004 CID_154699815 | ||
| 0.39 | 0.048 | 0.39 | Caspase 3 stimulant | 0.31 0.074 CID_779516 0.233 0.128 CID_154699815 | ||
| 0.34 | 0.004 | 0.869 | Cyclin E1 inhibitor | 0.239 0.005 CID_779516 0.869 0.002 CID_154699815 | CID_154699815 | |
| 0.424 | 0.092 | 0.424 | MAP kinase 1 inhibitor | 0.287 0.195 CID_779516 | ||
| 0.321 | 0.01 | 0.366 | Aldehyde dehydrogenase inhibitor | 0.366 0.007 CID_779516 0.274 0.014 CID_154699815 | CID_779516 | |
| 0.311 | 0.004 | 0.838 | Cyclin E inhibitor | 0.225 0.005 CID_779516 0.838 0.002 CID_154699815 | CID_154699815 | |
| 0.298 | 0.013 | 0.835 | Cyclin-dependent kinase 2 inhibitor | 0.176 0.03 CID_779516 0.835 0.004 CID_154699815 | CID_154699815 | |
| 0.291 | 0.02 | 0.291 | Tumour necrosis factor antagonist | 0.161 0.087 CID_779516 | ||
| 0.306 | 0.041 | 0.306 | Psychostimulant | 0.255 0.057 CID_779516 | ||
| 0.253 | 0.004 | 0.253 | Transcription factor AP-1 inhibitor | 0.205 0.005 CID_779516 0.188 0.005 CID_154699815 | ||
| 0.237 | 0.009 | 0.246 | Carbonic anhydrase VI inhibitor | 0.246 0.009 CID_779516 0.075 0.064 CID_154699815 | CID_779516 | |
| 0.353 | 0.129 | 0.353 | Transcription factor inhibitor | |||
| 0.229 | 0.006 | 0.229 | Potassium channel activator | 0.184 0.011 CID_779516 0.111 0.038 CID_154699815 | ||
| 0.229 | 0.01 | 0.229 | CF transmembrane conductance regulator agonist | 0.189 0.029 CID_779516 0.163 0.056 CID_154699815 | ||
| 0.239 | 0.024 | 0.239 | Heat shock protein 90 antagonist | |||
| 0.216 | 0.012 | 0.22 | Carbonic anhydrase XIII inhibitor | 0.22 0.012 CID_779516 0.076 0.053 CID_154699815 | CID_779516 | |
| 0.261 | 0.06 | 0.339 | DNA synthesis inhibitor | 0.339 0.033 CID_779516 0.246 0.069 CID_154699815 | CID_779516 | |
| 0.23 | 0.031 | 0.875 | Cyclin-dependent kinase inhibitor | 0.134 0.065 CID_779516 0.875 0.003 CID_154699815 | CID_154699815 | |
| 0.255 | 0.063 | 0.255 | Tyrosine 3 hydroxylase inhibitor | 0.232 0.088 CID_779516 0.194 0.148 CID_154699815 | ||
| 0.243 | 0.054 | 0.243 | RNA-directed DNA polymerase inhibitor | 0.23 0.064 CID_779516 0.205 0.092 CID_154699815 | ||
| 0.197 | 0.019 | 0.658 | CDK/cyclin complex inhibitor | 0.142 0.032 CID_779516 0.658 0.004 CID_154699815 | CID_154699815 | |
| 0.266 | 0.091 | 0.266 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | |||
| 0.175 | 0.012 | 0.175 | AXL receptor tyrosine kinase inhibitor | 0.1 0.04 CID_779516 | ||
| 0.174 | 0.011 | 0.177 | CDK1/cyclin B inhibitor | 0.177 0.011 CID_779516 0.084 0.031 CID_154699815 | CID_779516 | |
| 0.236 | 0.074 | 0.967 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.967 0.003 CID_154699815 | CID_154699815 | |
| 0.173 | 0.016 | 0.464 | p38 MAP kinase inhibitor | 0.464 0.005 CID_779516 | CID_779516 | |
| 0.161 | 0.004 | 0.161 | Catechol O-methyltransferase inhibitor | 0.119 0.004 CID_779516 0.131 0.004 CID_154699815 | ||
| 0.281 | 0.129 | 0.281 | GABA C receptor rho-3 antagonist | |||
| 0.157 | 0.01 | 0.219 | Purinergic P2X2 antagonist | 0.219 0.004 CID_779516 0.098 0.031 CID_154699815 | CID_779516 | |
| 0.146 | 0.002 | 0.146 | Prolactin release inhibitor | 0.123 0.003 CID_779516 0.099 0.005 CID_154699815 | ||
| 0.302 | 0.162 | 0.321 | 5 Hydroxytryptamine release inhibitor | 0.321 0.142 CID_779516 | CID_779516 | |
| 0.207 | 0.067 | 0.207 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | |||
| 0.148 | 0.012 | 0.148 | Carbonic anhydrase IX inhibitor | 0.078 0.028 CID_779516 0.078 0.028 CID_154699815 | ||
| 0.224 | 0.09 | 0.224 | Aryl hydrocarbon receptor agonist | |||
| 0.135 | 0.002 | 0.135 | Purinergic P2X agonist | 0.099 0.003 CID_779516 0.121 0.003 CID_154699815 | ||
| 0.146 | 0.013 | 0.146 | Carbonic anhydrase XII inhibitor | 0.074 0.027 CID_779516 | ||
| 0.137 | 0.011 | 0.227 | MAP kinase kinase 8 inhibitor | 0.227 0.005 CID_779516 | CID_779516 | |
| 0.142 | 0.016 | 0.142 | Carbonic anhydrase V inhibitor | 0.124 0.021 CID_779516 | ||
| 0.142 | 0.017 | 0.142 | Carbonic anhydrase inhibitor | 0.083 0.034 CID_779516 0.084 0.033 CID_154699815 | ||
| 0.215 | 0.09 | 0.966 | Dyrk kinase inhibitor | 0.966 0.003 CID_154699815 | CID_154699815 | |
| 0.135 | 0.014 | 0.135 | Carbonic anhydrase VA inhibitor | 0.118 0.019 CID_779516 | ||
| 0.131 | 0.011 | 0.131 | Carbonic anhydrase VB inhibitor | 0.118 0.013 CID_779516 0.048 0.047 CID_154699815 | ||
| 0.146 | 0.03 | 0.146 | CDK3/cyclin E inhibitor | 0.128 0.046 CID_779516 0.11 0.07 CID_154699815 | ||
| 0.143 | 0.03 | 0.143 | Pim-1 kinase inhibitor | |||
| 0.115 | 0.004 | 0.115 | Aggrecanase 1 inhibitor | 0.067 0.007 CID_779516 0.047 0.016 CID_154699815 | ||
| 0.135 | 0.028 | 0.135 | CDC-like kinase 3 inhibitor | 0.13 0.031 CID_779516 | ||
| 0.113 | 0.008 | 0.113 | Phosphodiesterase VII inhibitor | 0.084 0.023 CID_779516 | ||
| 0.122 | 0.017 | 0.349 | CDK2/cyclin E inhibitor | 0.077 0.032 CID_779516 0.349 0.004 CID_154699815 | CID_154699815 | |
| 0.118 | 0.02 | 0.118 | Adenosine A1 receptor antagonist | 0.064 0.036 CID_779516 | ||
| 0.114 | 0.016 | 0.114 | Carbonic anhydrase II inhibitor | 0.063 0.033 CID_779516 | ||
| 0.103 | 0.004 | 0.103 | Phosphodiesterase 7A inhibitor | 0.075 0.008 CID_779516 0.057 0.026 CID_154699815 | ||
| 0.151 | 0.055 | 0.214 | Alpha-N-acetylglucosaminidase inhibitor | 0.214 0.03 CID_779516 0.163 0.048 CID_154699815 | CID_779516 | |
| 0.115 | 0.02 | 0.115 | Adenosine A3 receptor antagonist | 0.088 0.034 CID_779516 | ||
| 0.192 | 0.098 | 0.192 | Potassium channel blocker | |||
| 0.302 | 0.21 | 0.302 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.108 | 0.016 | 0.108 | Carbonic anhydrase I inhibitor | 0.056 0.038 CID_779516 0.054 0.04 CID_154699815 | ||
| 0.153 | 0.063 | 0.153 | Lck kinase inhibitor | |||
| 0.219 | 0.13 | 0.219 | Hypoxia-inducible factor 1 alpha inhibitor | |||
| 0.121 | 0.033 | 0.121 | Phosphodiesterase IV inhibitor | 0.088 0.055 CID_779516 | ||
| 0.111 | 0.022 | 0.111 | CXC chemokine 4 receptor antagonist | |||
| 0.111 | 0.022 | 0.111 | Adenosine A2a receptor antagonist | 0.066 0.039 CID_779516 | ||
| 0.102 | 0.014 | 0.147 | Androgen agonist | 0.147 0.008 CID_779516 | CID_779516 | |
| 0.099 | 0.011 | 0.099 | Carbonic anhydrase XIV inhibitor | 0.091 0.013 CID_779516 | ||
| 0.092 | 0.005 | 0.092 | Potassium channel (Inward rectifier) activator | 0.072 0.01 CID_779516 | ||
| 0.09 | 0.004 | 0.09 | Purinergic P2Y2 antagonist | 0.069 0.006 CID_779516 0.083 0.005 CID_154699815 | ||
| 0.089 | 0.005 | 0.089 | Potassium channel (ATP-sensitive) activator | 0.069 0.01 CID_779516 | ||
| 0.108 | 0.025 | 0.108 | Adenosine A2 receptor antagonist | 0.06 0.048 CID_779516 | ||
| 0.113 | 0.034 | 0.129 | Aminoacyl-tRNA synthetase inhibitor | 0.129 0.026 CID_779516 | CID_779516 | |
| 0.237 | 0.159 | 0.523 | Immunosuppressant | 0.523 0.027 CID_779516 0.263 0.139 CID_154699815 | CID_779516 | |
| 0.186 | 0.114 | 0.186 | Nitric-oxide synthase stimulant | |||
| 0.125 | 0.055 | 0.77 | Cyclin-dependent kinase 5 inhibitor | 0.77 0.002 CID_154699815 | CID_154699815 | |
| 0.103 | 0.032 | 0.103 | Histamine H2 receptor antagonist | 0.081 0.063 CID_779516 | ||
| 0.073 | 0.004 | 0.073 | Adenosine A3 receptor agonist | 0.032 0.005 CID_779516 0.03 0.005 CID_154699815 | ||
| 0.151 | 0.082 | 0.151 | Src kinase inhibitor | |||
| 0.088 | 0.022 | 0.088 | Potassium channel (ATP-sensitive) blocker | 0.07 0.042 CID_779516 | ||
| 0.12 | 0.055 | 0.12 | MAP kinase 13 inhibitor | |||
| 0.096 | 0.032 | 0.107 | Interferon agonist | 0.107 0.023 CID_779516 | CID_779516 | |
| 0.079 | 0.016 | 0.846 | Cyclin B inhibitor | 0.846 0.002 CID_154699815 | CID_154699815 | |
| 0.139 | 0.076 | 0.139 | Lipid peroxidase inhibitor | |||
| 0.183 | 0.124 | 0.183 | Tumour necrosis factor alpha release inhibitor | |||
| 0.06 | 0.005 | 0.06 | Adenosine A1 receptor agonist | 0.042 0.007 CID_779516 0.048 0.006 CID_154699815 | ||
| 0.202 | 0.147 | 0.202 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.079 | 0.025 | 0.087 | Interferon inducer | 0.087 0.019 CID_779516 | CID_779516 | |
| 0.113 | 0.059 | 0.113 | Ferrochelatase inhibitor | 0.104 0.067 CID_154699815 | ||
| 0.106 | 0.053 | 0.565 | CDK2/cyclin A inhibitor | 0.565 0.004 CID_154699815 | CID_154699815 | |
| 0.098 | 0.048 | 0.098 | Polo-like kinase-1 inhibitor | |||
| 0.143 | 0.094 | 0.143 | Heat shock protein 90 alpha antagonist | |||
| 0.065 | 0.02 | 0.065 | Potassium channel (Inward rectifier) blocker | 0.049 0.035 CID_779516 | ||
| 0.069 | 0.026 | 0.081 | Gonadotropin-releasing hormone receptor agonist | 0.081 0.017 CID_779516 | CID_779516 | |
| 0.163 | 0.121 | 0.163 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | |||
| 0.064 | 0.023 | 0.064 | Histamine agonist | |||
| 0.171 | 0.132 | 0.171 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.074 | 0.036 | 0.079 | Cyclin A2 inhibitor | 0.079 0.033 CID_154699815 | CID_154699815 | |
| 0.056 | 0.018 | 0.056 | Nicotinic acid receptor 1 agonist | 0.041 0.028 CID_779516 0.04 0.029 CID_154699815 | ||
| 0.267 | 0.232 | 0.267 | Caspase 9 stimulant | |||
| 0.085 | 0.052 | 0.085 | Platelet growth factor antagonist | |||
| 0.044 | 0.011 | 0.13 | Cyclin E2 inhibitor | 0.048 0.01 CID_779516 0.13 0.004 CID_154699815 | CID_154699815 | |
| 0.171 | 0.138 | 0.249 | Immunostimulant | 0.249 0.097 CID_779516 0.166 0.142 CID_154699815 | CID_779516 | |
| 0.047 | 0.015 | 0.059 | Phosphoglycerate kinase inhibitor | 0.059 0.011 CID_779516 | CID_779516 | |
| 0.12 | 0.089 | 0.134 | Cytokine production inhibitor | 0.134 0.076 CID_779516 | CID_779516 | |
| 0.057 | 0.027 | 0.057 | Adenosine A2b receptor antagonist | |||
| 0.052 | 0.023 | 0.052 | CDK7/cyclin H inhibitor | 0.042 0.037 CID_779516 | ||
| 0.097 | 0.069 | 0.097 | GABA C receptor agonist | |||
| 0.032 | 0.005 | 0.032 | Adenosine A2 receptor agonist | 0.025 0.006 CID_779516 0.016 0.011 CID_154699815 | ||
| 0.083 | 0.056 | 0.083 | T cell inhibitor | |||
| 0.035 | 0.009 | 0.035 | Corticotropin releasing factor 1 receptor antagonist | 0.024 0.014 CID_779516 | ||
| 0.065 | 0.041 | 0.068 | Cyclin A inhibitor | 0.068 0.038 CID_154699815 | CID_154699815 | |
| 0.028 | 0.006 | 0.028 | Adenosine A2a receptor agonist | 0.025 0.007 CID_779516 | ||
| 0.025 | 0.004 | 0.025 | Adenosine A2b receptor agonist | 0.021 0.005 CID_779516 0.019 0.006 CID_154699815 | ||
| 0.127 | 0.108 | 0.127 | Adenylate cyclase stimulant | 0.126 0.11 CID_779516 | ||
| 0.024 | 0.005 | 0.024 | Potassium channel (Inward rectifier) 11 blocker | 0.017 0.016 CID_779516 0.02 0.009 CID_154699815 | ||
| 0.087 | 0.068 | 0.097 | Alcohol dehydrogenase inhibitor | 0.097 0.055 CID_779516 | CID_779516 | |
| 0.068 | 0.05 | 0.068 | CDK1/cyclin B1 inhibitor | |||
| 0.084 | 0.066 | 0.092 | NADH dehydrogenase inhibitor | 0.092 0.053 CID_779516 | CID_779516 | |
| 0.072 | 0.055 | 0.072 | Protein kinase B gamma inhibitor | |||
| 0.071 | 0.054 | 0.113 | MAP kinase 14 inhibitor | 0.113 0.03 CID_779516 | CID_779516 | |
| 0.067 | 0.053 | 0.163 | CXC chemokine receptor antagonist | 0.163 0.009 CID_779516 | CID_779516 | |
| 0.02 | 0.008 | 0.02 | Purinergic P2Y1 antagonist | 0.015 0.012 CID_154699815 | ||
| 0.038 | 0.026 | 0.038 | Potassium channel Kv1.1 blocker | |||
| 0.057 | 0.045 | 0.057 | Cyclin A1 inhibitor | |||
| 0.059 | 0.048 | 0.059 | Corticotropin releasing factor 2 receptor antagonist | |||
| 0.039 | 0.028 | 0.039 | Glucagon-like peptide 1 receptor antagonist | |||
| 0.103 | 0.093 | 0.103 | Epidermal growth factor receptor kinase inhibitor | |||
| 0.082 | 0.072 | 0.082 | Fibroblast growth factor 1 antagonist | |||
| 0.028 | 0.02 | 0.028 | Purinergic P2Y15 antagonist | |||
| 0.083 | 0.076 | 0.083 | Platelet activating factor beta antagonist | |||
| 0.193 | 0.188 | 0.21 | Vasodilator, coronary | 0.21 0.173 CID_779516 | CID_779516 | |
| 0.054 | 0.052 | 0.054 | Cyclin B1 inhibitor | |||
| 0.163 | 0.162 | 0.163 | 5 Hydroxytryptamine release stimulant | |||
| 0.049 | 0.048 | 0.049 | Cyclin B2 inhibitor | |||
| 0.107 | 0.115 | 0.119 | Peroxidase inhibitor | 0.119 0.1 CID_779516 | CID_779516 | |
| 0.047 | 0.06 | 0.085 | Carbamoyl phosphate synthetase inhibitor | 0.085 0.026 CID_779516 0.065 0.039 CID_154699815 | CID_779516 | |
| 0.12 | 0.134 | 0.125 | MAP kinase 3 inhibitor | 0.125 0.12 CID_779516 | CID_779516 | |
| 0.044 | 0.062 | 0.056 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.056 0.039 CID_779516 | CID_779516 | |
| 0.083 | 0.119 | 0.126 | MAP kinase kinase inhibitor | 0.126 0.068 CID_779516 | CID_779516 | |
| 0.063 | 0.103 | 0.075 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.075 0.073 CID_779516 | CID_779516 | |
| 0.037 | 0.079 | 0.06 | Alpha-mannosidase inhibitor | 0.06 0.026 CID_779516 | CID_779516 | |
| 0.029 | 0.072 | 0.053 | Ornithine carbamoyltransferase inhibitor | 0.053 0.037 CID_779516 | CID_779516 | |
| 0.044 | 0.09 | 0.089 | Phenylalanine 4-hydroxylase inhibitor | 0.089 0.031 CID_779516 | CID_779516 | |
| 0.01 | 0.058 | 0.024 | Follicle-stimulating hormone agonist | 0.024 0.013 CID_779516 | CID_779516 | |
| 0.032 | 0.084 | 0.054 | Raf kinase B inhibitor | 0.054 0.046 CID_779516 | CID_779516 | |
| 0.025 | 0.084 | 0.048 | Mannosidase inhibitor | 0.048 0.028 CID_779516 | CID_779516 | |
| 0.118 | 0.186 | 0.147 | Succinate dehydrogenase inhibitor | 0.147 0.118 CID_779516 | CID_779516 | |
| 0.058 | 0.138 | 0.095 | Creatine kinase inhibitor | 0.095 0.065 CID_779516 | CID_779516 | |
| 0.031 | 0.114 | 0.064 | Phosphofructokinase-1 inhibitor | 0.064 0.053 CID_779516 | CID_779516 | |
| 0.012 | 0.109 | 0.019 | Follicle-stimulating hormone antagonist | 0.019 0.016 CID_779516 | CID_779516 | |
| 0.136 | 0.238 | 0.339 | Peptidyltransferase inhibitor | 0.339 0.014 CID_779516 0.188 0.116 CID_154699815 | CID_779516 | |
| 0.132 | 0.256 | 0.226 | Cholesterol antagonist | 0.226 0.143 CID_779516 | CID_779516 | |
| 0.113 | 0.251 | 0.191 | Hypoglycemic | 0.191 0.121 CID_779516 | CID_779516 | |
| 0.068 | 0.213 | 0.155 | Angiogenesis stimulant | 0.155 0.12 CID_779516 | CID_779516 | |
| 0.131 | 0.276 | 0.274 | Immunomodulator | 0.274 0.097 CID_779516 | CID_779516 | |
| 0.017 | 0.217 | 0.036 | Antibiotic Aminoglycoside-like | 0.036 0.026 CID_154699815 | CID_154699815 | |
| 0.012 | 0.307 | 0.056 | Phosphatidylinositol 3-kinase gamma inhibitor | 0.056 0.036 CID_154699815 | CID_154699815 | |
| 0.003 | 0.674 | 0.062 | Sphingosine 1-phosphate receptor 3 agonist | 0.062 0.011 CID_779516 | CID_779516 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |